Treatment for Hip Fractures
This study is evaluating whether two types of standard care anesthesia are the same or if one is better for people who have hip fractures.
See full descriptionAbout the trial for Hip Fractures
Treatment Groups
This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Treatment will improve 1 primary outcome and 11 secondary outcomes in patients with Hip Fractures. Measurement will happen over the course of Before surgery and daily through postoperative day 3 or day of discharge, whichever occurs first.
Patient Q & A Section
What causes hip fractures?
Data from a recent study suggest that hip fracture is more complex (i.e. multifactorial, i.e. due to multiple etiologic factors) than has usually been described.
What is hip fractures?
Fracture related mortality in the UK has dropped sharply in the last 10 years. Age is an independent predictor of long term mortality. This supports previous work. But the impact of the change is not clear. Our work suggests that initiatives to implement fracture prevention programmes must be tailored for each age group.
What are common treatments for hip fractures?
There are several popular therapies used to treat hip fractures. The goals of treatment are to control pain and reduce the risk of complications associated with hip fractures such as infections or blood clots. The most common treatments for hip fractures include pain management, immobilization. and surgical fixation. Patients with hip fractures will often be treated on a level-dependency basis, where providers will classify patients based on a series of level, or severity of the fracture. Physicians assess fracture severity (class I-V) and tailor treatment and monitoring depending on the clinical level of the patient, rather than assigning a single level of treatment. For example, level I fractures (simple fractures), will often be treated with pain management while the patient is medically stable.
Can hip fractures be cured?
Hip fractures are associated with impaired survival and adverse functional outcomes compared with patients of similar age who have no history of hip fracture fracture, even after operative fixation of the hip.
How many people get hip fractures a year in the United States?
In the United States, every year the total cost for treatment of an hip fracture is at least $929 Million. More than 80% of the cost, roughly $844 Million, can be paid by Medicare and Medicaid. The projected lifetime costs of the most common treatment, percutaneous vertebroplasty, or PVP, for hip fractures may exceed $100,000. The total potential benefit of this intervention far exceeds this cost. These figures should be considered when deciding whether to pursue these procedures for the treatment of low energy hip fractures in the Medicare population.
What are the signs of hip fractures?
For the diagnosis of a "probable hip fracture," a combination of the signs can help to distinguish from other diagnoses by the emergency physicians. The symptoms in any of the signs cannot be separated.
What is the primary cause of hip fractures?
The primary cause of hip fracture was fracture due to trauma in the majority of our patients. Data from a recent study suggest that fall-related fractures may contribute to fracture in the elderly; thus, further studies on fall risk in elderly with a lower BMI are anticipated.
Have there been any new discoveries for treating hip fractures?
Since hip fractures are a leading cause of morbidity and mortality in the elderly population, the development and application of effective, low-cost, and readily translated therapies are urgently needed.
Is treatment typically used in combination with any other treatments?
Overall, the treatment recommended by ACOG was not used universally; the treatment most commonly used with other treatments was [staging surgeries followed by targeted therapy with an agents such as the anthracyclines, bortezomib-dexamethasone, and ixabeprole-dexamethasone (IBEX-D) combined with alkylating agents]. Because of the wide use of ACOG treatment, the use of treatment with agents such as ixabeprole-dexamethasone or IBEX-D seems to be appropriate, particularly in younger women.
Does treatment improve quality of life for those with hip fractures?
There was no improvement of health-related quality of life measured using the QWB questionnaire following treatment of hip fractures in older adults. Although the QWB instrument can be used to measure quality of life for the general population, the use is not appropriate in the evaluation of outcomes in health services and research studies.
What is the latest research for hip fractures?
Hip fracture research should focus on improving risk assessment to determine who may be at risk. Additional studies are needed to assess the benefits of specific drug and nonmedical interventions in preventing hip fractures.
What is the average age someone gets hip fractures?
Average age of hip fracture is 80 years. This number may be misleading however, it is not clear how much age plays a role in fractures because of the large percentage and wide age range that may represent people who were never exposed to a fracture.